genOway
José VIÑUELAS has extensive experience in molecular biology and multi-omics research, currently serving as Manager and Team Leader R&D at genOway since March 2015. In this role, responsibilities include managing R&D programs, overseeing multiple projects, and developing and optimizing technologies. Previous positions include leading R&D programs in Factory 4.0 at genOway, and managing synthesis biology projects at INSA Lyon. José VIÑUELAS has also held senior scientific roles at CNRS and junior scientific roles at INRA, contributing to projects focused on gene expression and genetic regulation. Educational qualifications encompass a doctorate in molecular biology, a Master's in microbiology, and an engineering degree in biochemistry and biotechnology, all obtained from INSA Lyon.
This person is not in any teams
This person is not in any offices
genOway
1 followers
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.